Abstract
Cerebral venous thrombosis (CVT) is a relatively uncommon but serious neurologic disorder that is potentially reversible with prompt diagnosis and appropriate medical care. The clinical presentation is extremely variable and nonspecific, and imaging is critical in diagnosis. Many risk factors for CVT have been reported, most of which overlap with those of peripheral venous thromboembolism. Patients can be diagnosed with magnetic resonance imaging, CT venography, or catheter angiography. The management of CVT patients includes treatment of associated conditions, anticoagulation with parenteral heparin, prevention of recurrent seizures, and surgical decompression in patients with large venous infarcts/hemorrhages with impending herniation. After the acute phase, patients should be anticoagulated for up to 3–12 months based on etiology. In patients who develop clinical and radiological signs of impending herniation, decompressive surgery can be both lifesaving and result in a good functional outcome. The prognosis is otherwise favorable in most cases, especially compared to arterial stroke, although a significant proportion of patients do suffer from chronic symptoms.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Gokhale S, Lahoti SA (2014) Therapeutic advances in understanding pathophysiology and treatment of cerebral venous sinus thrombosis. Am J Ther 21(2):137–139
Ferro JM, Canhao P, Stam J, Bousser MG, Barinagarrementeria F (2004) Prognosis of cerebral vein and dural sinus thrombosis: results of the international study on cerebral vein and dural sinus thrombosis (ISCVT). Stroke 35:664–670
Filippidis A, Kapsalaki E, Patramani G, Fountas KN (2009) Cerebral venous sinus thrombosis: review of the demographics, pathophysiology, current diagnosis, and treatment. Neurosurg Focus 27(5):E3
Yoshikawa T, Abe O, Tsuchiya K, Okubo T, Tobe K, Masumoto T et al (2002) Diffusion-weighted magnetic resonance imaging of dural sinus thrombosis. Neuroradiology 44:481–488
Saposnik G, Barinagarrementeria F, Brown RD Jr et al (2011) American Heart Association Stroke Council and the Council on Epidemiology and Prevention. Diagnosis and management of cerebral venous thrombosis: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 42:1158–1192
de Bruijn SFTM (2001) Clinical features and prognostic factors of cerebral venous sinus thrombosis in a prospective series of 59 patients. J Neurol Neurosurg Psychiatry 70(1):105–108
Dentali F (2006) Thrombophilic abnormalities, oral contraceptives, and risk of cerebral vein thrombosis: a meta-analysis. Blood 107(7):2766–2773
Bousser M-G, Crassard I (2012) Cerebral venous thrombosis, pregnancy and oral contraceptives. Thromb Res 130:S19–S22
Tchaikovski SN, Rosing J (2010) Mechanisms of estrogen induced venous thromboembolism. Thromb Res 126:5–11
Wysokinska EM, Wysokinski WE, Brown RD et al (2008) Thrombophilia differences in cerebral venous sinus and lower extremity deep venous thrombosis. Neurology 70:627–633
Coutinho J et al (2013) Cerebral venous thrombosis and thrombophilia: a systematic review and meta-analysis. Semin Thromb Hemost 39(8):913–927
Raper DMS et al (2016) Geographically remote cerebral venous sinus thrombosis in patients with intracranial tumors. World Neurosurg 98:555–562
Azin H, Ashjazadeh N (2008) Cerebral venous sinus thrombosis—clinical features, predisposing and prognostic factors. Acta Neurol Taiwan 17(2):82–87
Sparaco M, Feleppa M, Bigal ME (2015) Cerebral venous thrombosis and headache – a case-series. Headache 55(6):806–814
Ebright JR, Pace MT, Niazi AF (2001) Septic thrombosis of the cavernous sinuses. Arch Intern Med 161(22):2671–2676
Khatri IA, Wasay M (2016) Septic cerebral venous sinus thrombosis. J Neurol Sci 362:221–227
Bousser M-G, Ferro JM (2007) Cerebral venous thrombosis: an update. Lancet Neurol 6(2):162–170
Kumral E, Polat F, Uzunköprü C, Çallı C, Kitiş Ö (2011) The clinical spectrum of intracerebral hematoma, hemorrhagic infarct, non-hemorrhagic infarct, and non-lesional venous stroke in patients with cerebral sinus-venous thrombosis. Eur J Neurol 19(4):537–543. https://doi.org/10.1111/j.1468-1331.2011.03562
Simon S, Yao T, Ulm AJ, Rosenbaum BP, Mericle RA (2009) Dural arteriovenous fistulas masquerading as dural sinus thrombosis. J Neurosurg 110(3):514–517
Crassard I, Soria C, Tzourio C et al (2005) A negative D-dimer assay does not rule out cerebral venous thrombosis: a series of 73 patients. Stroke 36:1716–1719
Einhaupl K, Bousser MG, de Bruijn SF, Ferro JM, Martinelli I, Masuhr F, Stam J (2006) EFNS guideline on the treatment of cerebral venous and sinus thrombosis. Eur J Neurol 13(6):553–559
Einhaupl KM, Villringer A, Meister W, Mehraein S, Garner C, Pellkofer M, Haberl RL, Pfister HW, Schmiedek P (1991) Heparin treatment in sinus venous thrombosis [published correction appears in Lancet. 1991; 338:958]. Lancet 338:597–600
Misra UK, Kalita J, Chandra S, Kumar B et al (2012) Low molecular weight heparin versus unfractionated heparin in cerebral venous sinus thrombosis: a randomized controlled trial. Eur J Neurol 19:1030–1036
Canhao P, Cortesao A, Cabral M, Ferro JM, Stam J, Bousser MG, Barinagarrementeria F, ISCVT Investigators (2008) Are steroids useful to treat cerebral venous thrombosis? Stroke 39:105–110
Canhao P, Ferro JM, Lindgren AG et al (2005) Causes and predictors of death in cerebral venous thrombosis. Stroke 36:1720–1725
Ferro JM, Canhao P, Bousser MG, Stam J, Barinagarrementeria F, ISCVT Investigators (2008) Early seizures in cerebral vein and dural sinus thrombosis: risk factors and role of antiepileptics. Stroke 39:1152–1158
Van der Hulle T, Kooiman J, den Exter PL et al (2014) Effectiveness and safety of novel oral anticoagulants as compared with vitamin K antagonists in the treatment of acute symptomatic venous thromboembolism: a systematic review and meta-analysis. J Thromb Hemost 12(3):320–328
Shulman S, Kearon C, Kakkar AK et al (2009) Dabigatran versus warfarin in the treatment of acute venous thromboembolism. N Engl J Med 361:2342–2352
Geisbüsh C, Richter D, Herweh C, Ringleb PA, Nagel S (2014) Novel factor Xa inhibitor for the treatment of cerebral venous and sinus thrombosis – first experience in 7 patients. Stroke 45:2469–2471
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Jafari, S., Albin, C., Izzy, S. (2021). Cerebral Venous Thrombosis. In: Al-Mufti, MD, F., Amuluru MD, K. (eds) Cerebrovascular Disorders. Neuromethods, vol 170. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-1530-0_22
Download citation
DOI: https://doi.org/10.1007/978-1-0716-1530-0_22
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-0716-1529-4
Online ISBN: 978-1-0716-1530-0
eBook Packages: Springer Protocols